TRACON Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases.
REPORT RATINGS
4.8 / 5.0 (190)
Tracon Pharmaceuticals reports have an aggregate usefulness score of 4.8 based on 190 reviews.